Trials / Conditions / Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
Advanced Gastric or Gastroesophageal Junction Adenocarcinoma
4 registered clinical trials studyying Advanced Gastric or Gastroesophageal Junction Adenocarcinoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | JS107 vs Investigator's Choice as Second-line or Later Therapy for Advanced CLDN18.2-Positive Gastricor GEJ Ad NCT07284134 | Shanghai Junshi Bioscience Co., Ltd. | Phase 3 |
| Recruiting | Second-line Treatment With Serplulimab, Lenvatinib, and Paclitaxel in Advanced Gastric Cancer After Prior Immu NCT05585580 | Qilu Hospital of Shandong University | Phase 2 |
| Unknown | A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer. NCT04435652 | Qilu Pharmaceutical Co., Ltd. | Phase 2 / Phase 3 |
| Completed | A Study of Apatinib Tablets in the Treatment of Advanced or Metastatic Gastric Cancer NCT02426034 | Jiangsu HengRui Medicine Co., Ltd. | Phase 4 |